Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 Acute Trial: Effect on 3-Month Symptoms and Quality of Life

By sjmartinez • April 12, 2024

Greenstein YY, Hubel K, Froess J, Wisniewski SR, Venugopal V, Lai YH, Berger JS, Chang SY, Colovos C, Shah F, Kornblith LZ, Lawler PR, Gaddh M, Guerrero RM, Nkemdirim W, Lopes RD, Reynolds HR, Amigo JS, Wahid L, Zahra A, Goligher EC, Zarychanski R, Leifer E, Huang DT, Neal MD, Hochman JS, Cushman M, Gong MN. Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 Acute Trial: Effect on 3-Month Symptoms and Quality of Life. Chest. 2024 Apr;165(4):785-799. doi: 10.1016/j.chest.2023.11.019. Epub 2023 Nov 17. PMID: 37979717.

Tags: Anticoagulation, covid-19, Heparin, Publications, Pulmonary, Critical Care & Sleep Medicine, Quality of Life

Supporting Educational Excellence in Diversity (SEED): faculty development and allyship

Chadha P, Kang EH, Ngo V, Jorrin R, Kochai K, Ackerman-Barger K, Ton H. Supporting Educational Excellence in Diversity (SEED): faculty development and allyship. BMC[...]

Projected Mitigation of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B in the Gray Zone and the Immune-Tolerant Phase in the United States

Pak K, Sachar R, Saab S. Projected Mitigation of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B in the Gray Zone and the Immune-Tolerant Phase[...]

General movement assessments in neonates born with congenital gastrointestinal anomalies: a single site, retrospective study

Soumekh L, Bell S, Espinosa SL, Grogan T, Kesavan K, Calkins KL. General movement assessments in neonates born with congenital gastrointestinal anomalies: a single site,[...]